Official Title

An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Study Participants

    502
Five hundred patients with a confirmed clinical diagnosis of Cervical Dystonia (CD)are planned for enrollment into this open label study. These patients will be Type B toxin naive patients with CD. During this study patients will receive repeat injections of MYOBLOC when deemed appropriate by the Investigator. However, it will be recommended that injections occur not more frequently than every 12 weeks. Total duration of exposure to MYOBLOC will be targeted for at least two years, with potential exposure for up to 7 years in patients with earliest enrollment
Study Started
Jun 30
2001
Primary Completion
May 31
2008
Study Completion
Sep 30
2008
Results Posted
Sep 23
2009
Estimate
Last Update
May 10
2019

Biological Botulinum Toxin Type B

Eligible patients could receive injections of MYOBLOC once every 12 weeks. Total Dose could range from 5,000 Units up to 25,000 Units.

  • Other names: MYOBLOC

Criteria

Inclusion Criteria:

18 years of age or older
body weight of at least 46 kilograms
History of Cervical Dystonia of at least one year's duration who in the opinion of the Investigator requires treatment

Exclusion Criteria:

Inability to give informed consent
Patient who has been previously treated with botulinum Toxin Type B
Patient who has received a Botulinum toxin Type A injection in the last 12 weeks.
History of phenol injections involving the neck or shoulder region in the last 12 months.
Patients with neck contractures or cervical spine disease

Summary

MYOBLOC Open Label Treatment

All Events

Event Type Organ System Event Term MYOBLOC Open Label Treatment

Treatment Assessment Scale (TAS), 4 Wks Post-injection Compared to Baseline (Time 0), Rating of Cervical Dystonia Symptoms

7 point rating scale (-3 = significantly worse, 0 = no change, +3 = significantly better. Comparison at Wk 4 to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

0.9
points on a scale (Mean)
Standard Error: 0.1

Treatment Assessment Scale (TAS), Approx Wk 12 + 4 Wks Post-Injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point rating scale (-3=significantly worse, 0=no change, +3=significantly better), comparison of Wk 12 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.3
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 24 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). Comparison of Wk 24 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.5
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 36 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). Comparison of Wk 36 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.4
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 48 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). Comparison of Wk 48 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.5
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 60 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). comparison Wk 60 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.4
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 72 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). Comparison Wk 72 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.5
points on a scale (Mean)
Standard Deviation: 0.1

Treatment Assessment Scale (TAS), Approx Wk 84 + 4 Wks Post-injection Compared to Baseline. Rating of Cervical Dystonia Symptoms

7 point scale (-3=significantly worse, 0=no change, +3=significantly better). Comparison Wk 84 + 4, compared to baseline. Rating of Cervical Dystonia Symptoms

MYOBLOC Open Label Treatment

1.4
points on a scale (Mean)
Standard Deviation: 0.1

Age, Continuous

54
years (Mean)
Standard Deviation: 11

Age, Categorical

Region of Enrollment

Sex: Female, Male

MYOBLOC Treatment Session 1 (Time 0)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 2 (App 12 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 3 (App 24 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 4 (App 36 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 5 (App 48 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 6 (App 60 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 7 (App 72 Wks)

MYOBLOC Open Label Treatment

MYOBLOC Treatment Session 8 (App 84 Wks)

MYOBLOC Open Label Treatment